NN5401 (Insulin Degludec/Insulin Aspart)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NN5401 (Insulin Degludec/Insulin Aspart), covering 2017-02-10 to 2017-02-10. Get the full timeline:
Most recent: Clinical Trial Update: A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin Aspart) in Children, Adolescents and Adult Subjects With Type 1 Diabetes [Phase 1]